Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugo Castro

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Leukemia & Lymphoma|February 18, 2014
A prospective study of an alemtuzumab containing reduced-intensity allogeneic stem cell transplant program in patients with poor-risk and advanced lymphoid malignanciesCraig S Sauter, Joanne F Chou, Esperanza B Papadopoulos, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthJose M Aravena, Hugo Castro, Ronald Poblete, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 25, 2017
Allogeneic Hematopoietic Stem Cell Transplantation Is Underutilized in Older Patients with Myelodysplastic SyndromesBartlomiej M Getta, Ashwin Kishtagari, Patrick Hilden, et al.
JCO Global Oncology|May 17, 2021
Social Distancing and Economic Crisis During COVID-19 Pandemic Reduced Cancer Control in Latin America and Will Result in Increased Late-Stage Diagnoses and ExpenseTabaré Vázquez Rosas, Eduardo Cazap, Lucía Delgado, et al.
Pediatric Blood & Cancer|December 8, 2011
Paroxysmal nocturnal hemoglobinuria in pediatric patientsKevin J Curran, Nancy A Kernan, Susan E Prockop, et al.
British Journal of Haematology|February 6, 2016
The potential benefit of allogeneic over autologous transplantation in patients with very early relapsed and refractory follicular lymphoma with prior remission duration of ≤12 monthsMatthew A Lunning, Jocelyn C Migliacci, Patrick Hilden, et al.
Blood|June 10, 2006
Immunogenicity of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell (HC) transplantsDana Jaffe, Esperanza B Papadopoulos, James W Young, et al.
Leukemia & Lymphoma|June 11, 2014
Sirolimus, tacrolimus and low-dose methotrexate based graft-versus-host disease prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allogeneic hematopoietic cell transplantIzaskun Ceberio, Sean M Devlin, Craig Sauter, et al.
Sub-Cellular Biochemistry|January 16, 2020
Frataxin Structure and FunctionIgnacio Hugo Castro, María Florencia Pignataro, Karl Ellioth Sewell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 15, 2016
Cytomegalovirus Infection after CD34(+)-Selected Hematopoietic Cell TransplantationYao-Ting Huang, Dionysios Neofytos, Julia Foldi, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Leukemia & Lymphoma|February 18, 2014
A prospective study of an alemtuzumab containing reduced-intensity allogeneic stem cell transplant program in patients with poor-risk and advanced lymphoid malignanciesCraig S Sauter, Joanne F Chou, Esperanza B Papadopoulos, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthJose M Aravena, Hugo Castro, Ronald Poblete, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 25, 2017
Allogeneic Hematopoietic Stem Cell Transplantation Is Underutilized in Older Patients with Myelodysplastic SyndromesBartlomiej M Getta, Ashwin Kishtagari, Patrick Hilden, et al.
JCO Global Oncology|May 17, 2021
Social Distancing and Economic Crisis During COVID-19 Pandemic Reduced Cancer Control in Latin America and Will Result in Increased Late-Stage Diagnoses and ExpenseTabaré Vázquez Rosas, Eduardo Cazap, Lucía Delgado, et al.
Pediatric Blood & Cancer|December 8, 2011
Paroxysmal nocturnal hemoglobinuria in pediatric patientsKevin J Curran, Nancy A Kernan, Susan E Prockop, et al.
British Journal of Haematology|February 6, 2016
The potential benefit of allogeneic over autologous transplantation in patients with very early relapsed and refractory follicular lymphoma with prior remission duration of ≤12 monthsMatthew A Lunning, Jocelyn C Migliacci, Patrick Hilden, et al.
Blood|June 10, 2006
Immunogenicity of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell (HC) transplantsDana Jaffe, Esperanza B Papadopoulos, James W Young, et al.
Leukemia & Lymphoma|June 11, 2014
Sirolimus, tacrolimus and low-dose methotrexate based graft-versus-host disease prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allogeneic hematopoietic cell transplantIzaskun Ceberio, Sean M Devlin, Craig Sauter, et al.
Sub-Cellular Biochemistry|January 16, 2020
Frataxin Structure and FunctionIgnacio Hugo Castro, María Florencia Pignataro, Karl Ellioth Sewell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 15, 2016
Cytomegalovirus Infection after CD34(+)-Selected Hematopoietic Cell TransplantationYao-Ting Huang, Dionysios Neofytos, Julia Foldi, et al.
Pageof 9